EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Secretory kinase FAM20C triggers adipocyte dysfunction, inciting insulin resistance and inflammation in obesity

Ankit Gilani, Benjamin D Stein, Anne Hoffmann, Renan Pereira de Lima, Elizabeth E Ha, Edwin A Homan, Lunkun Ma, Alfonso Rubio-Navarro, Tint Tha Ra Wun, Gabriel Jose Ayala Carrascal, Bhavneet Bhinder, Adhideb Ghosh und 5 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci191075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Ankit Gilani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Weill Center for Metabolic Health, Cardiovascular Research Institute, and. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, Adipocytes, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a major driver of type 2 diabetes (T2D) and related metabolic disorders, characterized by chronic inflammation and adipocyte dysfunction. However, the molecular triggers initiating these processes remain poorly understood. We identified FAM20C, a serine/threonine kinase, as an early obesity-induced mediator of adipocyte dysfunction. Fam20c expression was substantially upregulated in adipocytes in response to obesity, correlating with a proinflammatory transcriptional signature. Forced expression of Fam20c in adipocytes promoted robust upregulation of proinflammatory cytokines and induced insulin resistance that is dependent on its kinase activity. Conversely, deletion of adipocyte Fam20c after established obesity and hyperglycemia improved glucose tolerance, augmented insulin sensitivity, and reduced visceral adiposity, without altering body weight. Phosphoproteomic studies revealed that FAM20C regulates phosphorylation of intracellular and secreted proteins, modulating pathways critical to inflammation, metabolism, and ECM remodeling. We identified FAM20C-dependent substrates, such as CNPY4, whose phosphorylation contributes to proinflammatory adipocyte signaling. Of translational relevance, we showed that in humans, visceral adipose FAM20C expression positively correlates with insulin resistance. Our findings establish FAM20C as an early regulator of obesity-induced adipocyte dysfunction and systemic metabolic impairment. Our studies provide proof of concept that inhibition of FAM20C may serve as a potential therapy for T2D by restoring adipocyte health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceObesityAdipocytesInflammationProtein Serine-Threonine KinasesAnimalsHumansMiceMaleMice, Knockout3T3-L1 CellsIntra-Abdominal FatPhosphorylationDiabetes Mellitus, Type 2Extracellular Matrix ProteinsCasein Kinase I

Stichwörter der Autor:innen

Adipose tissueCell biologyDiabetesMetabolismObesity

Substanzen

FAM20C protein, humanProtein Serine-Threonine KinasesExtracellular Matrix ProteinsCasein Kinase I

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Weill Center for Metabolic Health, Cardiovascular Research Institute, and.
  • Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Helmholtz Institute for Metabolic, Obesity, and Vascular Research, Helmholtz Center Munich, University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
  • Englander Institute of Precision Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Institute of Food, Nutrition and Health, ETH Zurich, Switzerland.
  • Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • American Diabetes Association
  • National Institute of Allergy and Infectious Diseases
  • American Heart Association
  • German Research Foundation

Zitieren

APA

Gilani, A., Stein, B. D., Hoffmann, A., Pereira de Lima, R., Ha, E. E., Homan, E. A., Ma, L., Rubio-Navarro, A., Tha Ra Wun, T., Ayala Carrascal, G. J., Bhinder, B., Ghosh, A., Noé, F., Elemento, O., Wolfrum, C., Blüher, M., & Lo, J. C. (2026). Secretory kinase FAM20C triggers adipocyte dysfunction, inciting insulin resistance and inflammation in obesity. Journal of Clinical Investigation. https://doi.org/10.1172/jci191075

Vancouver

Gilani A, Stein BD, Hoffmann A, Pereira de Lima R, Ha EE, Homan EA, et al. Secretory kinase FAM20C triggers adipocyte dysfunction, inciting insulin resistance and inflammation in obesity. Journal of Clinical Investigation. 2026. doi:10.1172/jci191075

BibTeX
@article{Gilani2026,
  author = {Gilani, Ankit and Stein, Benjamin D and Hoffmann, Anne and Pereira de Lima, Renan and Ha, Elizabeth E and Homan, Edwin A and Ma, Lunkun and Rubio-Navarro, Alfonso and Tha Ra Wun, Tint and Ayala Carrascal, Gabriel Jose and Bhinder, Bhavneet and Ghosh, Adhideb and Noé, Falko and Elemento, Olivier and Wolfrum, Christian and Blüher, Matthias and Lo, James C},
  title = {Secretory kinase FAM20C triggers adipocyte dysfunction, inciting insulin resistance and inflammation in obesity},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci191075}
}
Kostenlos starten →